2-(3-phenoxyphenylamino)benzoic acid

ID: ALA3931520

Chembl Id: CHEMBL3931520

PubChem CID: 44521008

Max Phase: Preclinical

Molecular Formula: C19H15NO3

Molecular Weight: 305.33

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)c1ccccc1Nc1cccc(Oc2ccccc2)c1

Standard InChI:  InChI=1S/C19H15NO3/c21-19(22)17-11-4-5-12-18(17)20-14-7-6-10-16(13-14)23-15-8-2-1-3-9-15/h1-13,20H,(H,21,22)

Standard InChI Key:  ACFBDJYMPSIKOW-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

KCNK18 Tclin Potassium channel subfamily K member 18 (30 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 305.33Molecular Weight (Monoisotopic): 305.1052AlogP: 4.92#Rotatable Bonds: 5
Polar Surface Area: 58.56Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.87CX Basic pKa: CX LogP: 5.87CX LogD: 2.64
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.70Np Likeness Score: -0.85

References

1. Monteillier A, Loucif A, Omoto K, Stevens EB, Lainez S, Saintot PP, Cao L, Pryde DC..  (2016)  Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1.,  26  (20): [PMID:27641472] [10.1016/j.bmcl.2016.09.020]

Source